nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—CYP2E1—Thalidomide—hematologic cancer	0.0401	0.0558	CbGbCtD
Sulfadiazine—CYP2C9—Bexarotene—hematologic cancer	0.0391	0.0545	CbGbCtD
Sulfadiazine—CYP2E1—Dacarbazine—hematologic cancer	0.0345	0.048	CbGbCtD
Sulfadiazine—CYP2C8—Bortezomib—hematologic cancer	0.0344	0.0479	CbGbCtD
Sulfadiazine—CYP2C9—Idarubicin—hematologic cancer	0.0324	0.0452	CbGbCtD
Sulfadiazine—CYP2E1—Mitoxantrone—hematologic cancer	0.0267	0.0373	CbGbCtD
Sulfadiazine—CYP2C8—Ifosfamide—hematologic cancer	0.0264	0.0367	CbGbCtD
Sulfadiazine—CYP2C9—Bortezomib—hematologic cancer	0.024	0.0334	CbGbCtD
Sulfadiazine—CYP2C8—Nilotinib—hematologic cancer	0.0229	0.0319	CbGbCtD
Sulfadiazine—CYP3A4—Bexarotene—hematologic cancer	0.0227	0.0317	CbGbCtD
Sulfadiazine—CYP3A4—Lomustine—hematologic cancer	0.0211	0.0295	CbGbCtD
Sulfadiazine—CYP3A4—Busulfan—hematologic cancer	0.0211	0.0295	CbGbCtD
Sulfadiazine—CYP2C9—Thalidomide—hematologic cancer	0.0209	0.0291	CbGbCtD
Sulfadiazine—CYP2C9—Teniposide—hematologic cancer	0.0199	0.0278	CbGbCtD
Sulfadiazine—CYP3A4—Thiotepa—hematologic cancer	0.0188	0.0263	CbGbCtD
Sulfadiazine—CYP2C9—Ifosfamide—hematologic cancer	0.0184	0.0256	CbGbCtD
Sulfadiazine—CYP2C9—Imatinib—hematologic cancer	0.0176	0.0245	CbGbCtD
Sulfadiazine—CYP2E1—Etoposide—hematologic cancer	0.0169	0.0235	CbGbCtD
Sulfadiazine—CYP2C9—Nilotinib—hematologic cancer	0.016	0.0222	CbGbCtD
Sulfadiazine—CYP3A4—Methoxsalen—hematologic cancer	0.0147	0.0204	CbGbCtD
Sulfadiazine—CYP3A4—Bortezomib—hematologic cancer	0.0139	0.0194	CbGbCtD
Sulfadiazine—CYP2E1—Dexamethasone—hematologic cancer	0.0139	0.0193	CbGbCtD
Sulfadiazine—CYP3A4—Daunorubicin—hematologic cancer	0.0133	0.0186	CbGbCtD
Sulfadiazine—CYP2C8—Etoposide—hematologic cancer	0.0126	0.0176	CbGbCtD
Sulfadiazine—CYP3A4—Cytarabine—hematologic cancer	0.0118	0.0164	CbGbCtD
Sulfadiazine—CYP3A4—Teniposide—hematologic cancer	0.0116	0.0161	CbGbCtD
Sulfadiazine—CYP3A4—Ifosfamide—hematologic cancer	0.0107	0.0149	CbGbCtD
Sulfadiazine—CYP2C8—Dexamethasone—hematologic cancer	0.0104	0.0144	CbGbCtD
Sulfadiazine—CYP3A4—Imatinib—hematologic cancer	0.0102	0.0142	CbGbCtD
Sulfadiazine—CYP3A4—Ruxolitinib—hematologic cancer	0.00962	0.0134	CbGbCtD
Sulfadiazine—CYP3A4—Nilotinib—hematologic cancer	0.00928	0.0129	CbGbCtD
Sulfadiazine—CYP3A4—Vinorelbine—hematologic cancer	0.0092	0.0128	CbGbCtD
Sulfadiazine—CYP2C9—Cisplatin—hematologic cancer	0.00894	0.0125	CbGbCtD
Sulfadiazine—CYP3A4—Triamcinolone—hematologic cancer	0.00842	0.0117	CbGbCtD
Sulfadiazine—CYP3A4—Dasatinib—hematologic cancer	0.0082	0.0114	CbGbCtD
Sulfadiazine—CYP3A4—Mitoxantrone—hematologic cancer	0.0081	0.0113	CbGbCtD
Sulfadiazine—CYP2C9—Dexamethasone—hematologic cancer	0.00722	0.0101	CbGbCtD
Sulfadiazine—CYP3A4—Betamethasone—hematologic cancer	0.00722	0.0101	CbGbCtD
Sulfadiazine—CYP3A4—Prednisolone—hematologic cancer	0.00713	0.00993	CbGbCtD
Sulfadiazine—CYP3A4—Prednisone—hematologic cancer	0.00673	0.00938	CbGbCtD
Sulfadiazine—CYP3A4—Irinotecan—hematologic cancer	0.00638	0.00889	CbGbCtD
Sulfadiazine—CYP3A4—Vinblastine—hematologic cancer	0.00567	0.0079	CbGbCtD
Sulfadiazine—CYP3A4—Vincristine—hematologic cancer	0.00558	0.00777	CbGbCtD
Sulfadiazine—CYP3A4—Etoposide—hematologic cancer	0.00511	0.00712	CbGbCtD
Sulfadiazine—CYP3A4—Dexamethasone—hematologic cancer	0.0042	0.00585	CbGbCtD
Sulfadiazine—CYP3A4—Doxorubicin—hematologic cancer	0.00348	0.00486	CbGbCtD
Sulfadiazine—Sulfasalazine—ALOX5—hematologic cancer	0.000698	0.259	CrCbGaD
Sulfadiazine—Sulfanilamide—CA9—hematologic cancer	0.000434	0.161	CrCbGaD
Sulfadiazine—Sulfasalazine—ABCG2—hematologic cancer	0.000345	0.128	CrCbGaD
Sulfadiazine—Sulfamethazine—ALB—hematologic cancer	0.000293	0.109	CrCbGaD
Sulfadiazine—Dapsone—MPO—hematologic cancer	0.000292	0.108	CrCbGaD
Sulfadiazine—Sulfamerazine—ALB—hematologic cancer	0.000286	0.106	CrCbGaD
Sulfadiazine—Sulfamethizole—ALB—hematologic cancer	0.000222	0.0824	CrCbGaD
Sulfadiazine—Sulfamethoxazole—ALB—hematologic cancer	0.000125	0.0462	CrCbGaD
Sulfadiazine—Anaphylactic shock—Triamcinolone—hematologic cancer	8.41e-05	0.000301	CcSEcCtD
Sulfadiazine—Pruritus—Alitretinoin—hematologic cancer	8.4e-05	0.0003	CcSEcCtD
Sulfadiazine—Vertigo—Dexamethasone—hematologic cancer	8.4e-05	0.0003	CcSEcCtD
Sulfadiazine—Vertigo—Betamethasone—hematologic cancer	8.4e-05	0.0003	CcSEcCtD
Sulfadiazine—Pruritus—Ifosfamide—hematologic cancer	8.31e-05	0.000297	CcSEcCtD
Sulfadiazine—Pancreatitis—Doxorubicin—hematologic cancer	8.29e-05	0.000296	CcSEcCtD
Sulfadiazine—Insomnia—Prednisolone—hematologic cancer	8.27e-05	0.000296	CcSEcCtD
Sulfadiazine—Nausea—Bortezomib—hematologic cancer	8.22e-05	0.000294	CcSEcCtD
Sulfadiazine—Hypersensitivity—Mitoxantrone—hematologic cancer	8.21e-05	0.000294	CcSEcCtD
Sulfadiazine—Hypersensitivity—Irinotecan—hematologic cancer	8.21e-05	0.000294	CcSEcCtD
Sulfadiazine—Vomiting—Thiotepa—hematologic cancer	8.21e-05	0.000293	CcSEcCtD
Sulfadiazine—Diarrhoea—Carmustine—hematologic cancer	8.2e-05	0.000293	CcSEcCtD
Sulfadiazine—Nausea—Bleomycin—hematologic cancer	8.16e-05	0.000292	CcSEcCtD
Sulfadiazine—Rash—Thiotepa—hematologic cancer	8.14e-05	0.000291	CcSEcCtD
Sulfadiazine—Dermatitis—Thiotepa—hematologic cancer	8.13e-05	0.000291	CcSEcCtD
Sulfadiazine—Diarrhoea—Alitretinoin—hematologic cancer	8.13e-05	0.000291	CcSEcCtD
Sulfadiazine—Agranulocytosis—Methotrexate—hematologic cancer	8.13e-05	0.000291	CcSEcCtD
Sulfadiazine—Convulsion—Dexamethasone—hematologic cancer	8.1e-05	0.00029	CcSEcCtD
Sulfadiazine—Convulsion—Betamethasone—hematologic cancer	8.1e-05	0.00029	CcSEcCtD
Sulfadiazine—Headache—Thiotepa—hematologic cancer	8.09e-05	0.000289	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Epirubicin—hematologic cancer	8.08e-05	0.000289	CcSEcCtD
Sulfadiazine—Decreased appetite—Etoposide—hematologic cancer	8.06e-05	0.000288	CcSEcCtD
Sulfadiazine—Diarrhoea—Ifosfamide—hematologic cancer	8.03e-05	0.000287	CcSEcCtD
Sulfadiazine—Nausea—Vinorelbine—hematologic cancer	8.03e-05	0.000287	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Etoposide—hematologic cancer	8.01e-05	0.000286	CcSEcCtD
Sulfadiazine—Body temperature increased—Cisplatin—hematologic cancer	8e-05	0.000286	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Epirubicin—hematologic cancer	7.99e-05	0.000286	CcSEcCtD
Sulfadiazine—Stomatitis—Epirubicin—hematologic cancer	7.94e-05	0.000284	CcSEcCtD
Sulfadiazine—Vomiting—Thalidomide—hematologic cancer	7.94e-05	0.000284	CcSEcCtD
Sulfadiazine—Rash—Thalidomide—hematologic cancer	7.87e-05	0.000281	CcSEcCtD
Sulfadiazine—Dermatitis—Thalidomide—hematologic cancer	7.86e-05	0.000281	CcSEcCtD
Sulfadiazine—Diarrhoea—Vincristine—hematologic cancer	7.83e-05	0.00028	CcSEcCtD
Sulfadiazine—Headache—Thalidomide—hematologic cancer	7.82e-05	0.00028	CcSEcCtD
Sulfadiazine—Hepatitis—Methotrexate—hematologic cancer	7.82e-05	0.00028	CcSEcCtD
Sulfadiazine—Pruritus—Gemcitabine—hematologic cancer	7.68e-05	0.000275	CcSEcCtD
Sulfadiazine—Nausea—Thiotepa—hematologic cancer	7.67e-05	0.000274	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	7.66e-05	0.000274	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Betamethasone—hematologic cancer	7.63e-05	0.000273	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Dexamethasone—hematologic cancer	7.63e-05	0.000273	CcSEcCtD
Sulfadiazine—Diarrhoea—Irinotecan—hematologic cancer	7.63e-05	0.000273	CcSEcCtD
Sulfadiazine—Diarrhoea—Mitoxantrone—hematologic cancer	7.63e-05	0.000273	CcSEcCtD
Sulfadiazine—Vomiting—Carmustine—hematologic cancer	7.62e-05	0.000273	CcSEcCtD
Sulfadiazine—Insomnia—Triamcinolone—hematologic cancer	7.61e-05	0.000272	CcSEcCtD
Sulfadiazine—Agranulocytosis—Epirubicin—hematologic cancer	7.61e-05	0.000272	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Etoposide—hematologic cancer	7.58e-05	0.000271	CcSEcCtD
Sulfadiazine—Rash—Carmustine—hematologic cancer	7.56e-05	0.00027	CcSEcCtD
Sulfadiazine—Dermatitis—Carmustine—hematologic cancer	7.55e-05	0.00027	CcSEcCtD
Sulfadiazine—Vomiting—Alitretinoin—hematologic cancer	7.55e-05	0.00027	CcSEcCtD
Sulfadiazine—Headache—Carmustine—hematologic cancer	7.51e-05	0.000269	CcSEcCtD
Sulfadiazine—Rash—Alitretinoin—hematologic cancer	7.49e-05	0.000268	CcSEcCtD
Sulfadiazine—Dermatitis—Alitretinoin—hematologic cancer	7.48e-05	0.000268	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	7.48e-05	0.000267	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Dexamethasone—hematologic cancer	7.47e-05	0.000267	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Betamethasone—hematologic cancer	7.47e-05	0.000267	CcSEcCtD
Sulfadiazine—Vomiting—Ifosfamide—hematologic cancer	7.46e-05	0.000267	CcSEcCtD
Sulfadiazine—Hypersensitivity—Cisplatin—hematologic cancer	7.46e-05	0.000267	CcSEcCtD
Sulfadiazine—Headache—Alitretinoin—hematologic cancer	7.44e-05	0.000266	CcSEcCtD
Sulfadiazine—Diarrhoea—Gemcitabine—hematologic cancer	7.43e-05	0.000266	CcSEcCtD
Sulfadiazine—Nausea—Thalidomide—hematologic cancer	7.42e-05	0.000265	CcSEcCtD
Sulfadiazine—Rash—Ifosfamide—hematologic cancer	7.4e-05	0.000265	CcSEcCtD
Sulfadiazine—Dermatitis—Ifosfamide—hematologic cancer	7.4e-05	0.000264	CcSEcCtD
Sulfadiazine—Erythema multiforme—Methotrexate—hematologic cancer	7.39e-05	0.000264	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Doxorubicin—hematologic cancer	7.39e-05	0.000264	CcSEcCtD
Sulfadiazine—Urticaria—Etoposide—hematologic cancer	7.37e-05	0.000263	CcSEcCtD
Sulfadiazine—Stomatitis—Doxorubicin—hematologic cancer	7.35e-05	0.000263	CcSEcCtD
Sulfadiazine—Body temperature increased—Etoposide—hematologic cancer	7.33e-05	0.000262	CcSEcCtD
Sulfadiazine—Abdominal pain—Etoposide—hematologic cancer	7.33e-05	0.000262	CcSEcCtD
Sulfadiazine—Vertigo—Prednisone—hematologic cancer	7.32e-05	0.000262	CcSEcCtD
Sulfadiazine—Hepatitis—Epirubicin—hematologic cancer	7.32e-05	0.000262	CcSEcCtD
Sulfadiazine—Tinnitus—Methotrexate—hematologic cancer	7.29e-05	0.000261	CcSEcCtD
Sulfadiazine—Vomiting—Vincristine—hematologic cancer	7.28e-05	0.00026	CcSEcCtD
Sulfadiazine—Anorexia—Dexamethasone—hematologic cancer	7.27e-05	0.00026	CcSEcCtD
Sulfadiazine—Anorexia—Betamethasone—hematologic cancer	7.27e-05	0.00026	CcSEcCtD
Sulfadiazine—Urticaria—Prednisolone—hematologic cancer	7.27e-05	0.00026	CcSEcCtD
Sulfadiazine—Rash—Vincristine—hematologic cancer	7.22e-05	0.000258	CcSEcCtD
Sulfadiazine—Dermatitis—Vincristine—hematologic cancer	7.21e-05	0.000258	CcSEcCtD
Sulfadiazine—Headache—Vincristine—hematologic cancer	7.17e-05	0.000256	CcSEcCtD
Sulfadiazine—Nausea—Carmustine—hematologic cancer	7.12e-05	0.000255	CcSEcCtD
Sulfadiazine—Vomiting—Irinotecan—hematologic cancer	7.09e-05	0.000253	CcSEcCtD
Sulfadiazine—Vomiting—Mitoxantrone—hematologic cancer	7.09e-05	0.000253	CcSEcCtD
Sulfadiazine—Nausea—Alitretinoin—hematologic cancer	7.06e-05	0.000252	CcSEcCtD
Sulfadiazine—Convulsion—Prednisone—hematologic cancer	7.06e-05	0.000252	CcSEcCtD
Sulfadiazine—Agranulocytosis—Doxorubicin—hematologic cancer	7.04e-05	0.000252	CcSEcCtD
Sulfadiazine—Rash—Mitoxantrone—hematologic cancer	7.03e-05	0.000251	CcSEcCtD
Sulfadiazine—Rash—Irinotecan—hematologic cancer	7.03e-05	0.000251	CcSEcCtD
Sulfadiazine—Dermatitis—Irinotecan—hematologic cancer	7.02e-05	0.000251	CcSEcCtD
Sulfadiazine—Dermatitis—Mitoxantrone—hematologic cancer	7.02e-05	0.000251	CcSEcCtD
Sulfadiazine—Chills—Methotrexate—hematologic cancer	7.01e-05	0.000251	CcSEcCtD
Sulfadiazine—Headache—Irinotecan—hematologic cancer	6.98e-05	0.00025	CcSEcCtD
Sulfadiazine—Headache—Mitoxantrone—hematologic cancer	6.98e-05	0.00025	CcSEcCtD
Sulfadiazine—Nausea—Ifosfamide—hematologic cancer	6.97e-05	0.000249	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	6.95e-05	0.000249	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	6.95e-05	0.000249	CcSEcCtD
Sulfadiazine—Arthralgia—Prednisone—hematologic cancer	6.93e-05	0.000248	CcSEcCtD
Sulfadiazine—Diarrhoea—Cisplatin—hematologic cancer	6.93e-05	0.000248	CcSEcCtD
Sulfadiazine—Erythema multiforme—Epirubicin—hematologic cancer	6.92e-05	0.000247	CcSEcCtD
Sulfadiazine—Vomiting—Gemcitabine—hematologic cancer	6.9e-05	0.000247	CcSEcCtD
Sulfadiazine—Insomnia—Dexamethasone—hematologic cancer	6.9e-05	0.000247	CcSEcCtD
Sulfadiazine—Insomnia—Betamethasone—hematologic cancer	6.9e-05	0.000247	CcSEcCtD
Sulfadiazine—Rash—Gemcitabine—hematologic cancer	6.85e-05	0.000245	CcSEcCtD
Sulfadiazine—Dermatitis—Gemcitabine—hematologic cancer	6.84e-05	0.000245	CcSEcCtD
Sulfadiazine—Hypersensitivity—Etoposide—hematologic cancer	6.83e-05	0.000244	CcSEcCtD
Sulfadiazine—Tinnitus—Epirubicin—hematologic cancer	6.82e-05	0.000244	CcSEcCtD
Sulfadiazine—Headache—Gemcitabine—hematologic cancer	6.8e-05	0.000243	CcSEcCtD
Sulfadiazine—Nausea—Vincristine—hematologic cancer	6.8e-05	0.000243	CcSEcCtD
Sulfadiazine—Hepatitis—Doxorubicin—hematologic cancer	6.77e-05	0.000242	CcSEcCtD
Sulfadiazine—Hypersensitivity—Prednisolone—hematologic cancer	6.74e-05	0.000241	CcSEcCtD
Sulfadiazine—Urticaria—Triamcinolone—hematologic cancer	6.68e-05	0.000239	CcSEcCtD
Sulfadiazine—Body temperature increased—Triamcinolone—hematologic cancer	6.65e-05	0.000238	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Prednisone—hematologic cancer	6.65e-05	0.000238	CcSEcCtD
Sulfadiazine—Decreased appetite—Dexamethasone—hematologic cancer	6.63e-05	0.000237	CcSEcCtD
Sulfadiazine—Decreased appetite—Betamethasone—hematologic cancer	6.63e-05	0.000237	CcSEcCtD
Sulfadiazine—Nausea—Irinotecan—hematologic cancer	6.62e-05	0.000237	CcSEcCtD
Sulfadiazine—Nausea—Mitoxantrone—hematologic cancer	6.62e-05	0.000237	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Betamethasone—hematologic cancer	6.59e-05	0.000236	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	6.59e-05	0.000236	CcSEcCtD
Sulfadiazine—Chills—Epirubicin—hematologic cancer	6.56e-05	0.000235	CcSEcCtD
Sulfadiazine—Pruritus—Etoposide—hematologic cancer	6.56e-05	0.000235	CcSEcCtD
Sulfadiazine—Nausea—Gemcitabine—hematologic cancer	6.45e-05	0.000231	CcSEcCtD
Sulfadiazine—Vomiting—Cisplatin—hematologic cancer	6.44e-05	0.00023	CcSEcCtD
Sulfadiazine—Erythema multiforme—Doxorubicin—hematologic cancer	6.4e-05	0.000229	CcSEcCtD
Sulfadiazine—Rash—Cisplatin—hematologic cancer	6.38e-05	0.000228	CcSEcCtD
Sulfadiazine—Dermatitis—Cisplatin—hematologic cancer	6.38e-05	0.000228	CcSEcCtD
Sulfadiazine—Diarrhoea—Etoposide—hematologic cancer	6.34e-05	0.000227	CcSEcCtD
Sulfadiazine—Anorexia—Prednisone—hematologic cancer	6.33e-05	0.000226	CcSEcCtD
Sulfadiazine—Tinnitus—Doxorubicin—hematologic cancer	6.31e-05	0.000226	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Dexamethasone—hematologic cancer	6.24e-05	0.000223	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Betamethasone—hematologic cancer	6.24e-05	0.000223	CcSEcCtD
Sulfadiazine—Hypersensitivity—Triamcinolone—hematologic cancer	6.2e-05	0.000222	CcSEcCtD
Sulfadiazine—Vertigo—Methotrexate—hematologic cancer	6.11e-05	0.000219	CcSEcCtD
Sulfadiazine—Leukopenia—Methotrexate—hematologic cancer	6.09e-05	0.000218	CcSEcCtD
Sulfadiazine—Chills—Doxorubicin—hematologic cancer	6.07e-05	0.000217	CcSEcCtD
Sulfadiazine—Urticaria—Betamethasone—hematologic cancer	6.06e-05	0.000217	CcSEcCtD
Sulfadiazine—Urticaria—Dexamethasone—hematologic cancer	6.06e-05	0.000217	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Prednisone—hematologic cancer	6.05e-05	0.000216	CcSEcCtD
Sulfadiazine—Abdominal pain—Betamethasone—hematologic cancer	6.03e-05	0.000216	CcSEcCtD
Sulfadiazine—Body temperature increased—Dexamethasone—hematologic cancer	6.03e-05	0.000216	CcSEcCtD
Sulfadiazine—Body temperature increased—Betamethasone—hematologic cancer	6.03e-05	0.000216	CcSEcCtD
Sulfadiazine—Abdominal pain—Dexamethasone—hematologic cancer	6.03e-05	0.000216	CcSEcCtD
Sulfadiazine—Nausea—Cisplatin—hematologic cancer	6.01e-05	0.000215	CcSEcCtD
Sulfadiazine—Insomnia—Prednisone—hematologic cancer	6.01e-05	0.000215	CcSEcCtD
Sulfadiazine—Pruritus—Triamcinolone—hematologic cancer	5.95e-05	0.000213	CcSEcCtD
Sulfadiazine—Convulsion—Methotrexate—hematologic cancer	5.9e-05	0.000211	CcSEcCtD
Sulfadiazine—Vomiting—Etoposide—hematologic cancer	5.9e-05	0.000211	CcSEcCtD
Sulfadiazine—Rash—Etoposide—hematologic cancer	5.85e-05	0.000209	CcSEcCtD
Sulfadiazine—Dermatitis—Etoposide—hematologic cancer	5.84e-05	0.000209	CcSEcCtD
Sulfadiazine—Headache—Etoposide—hematologic cancer	5.81e-05	0.000208	CcSEcCtD
Sulfadiazine—Arthralgia—Methotrexate—hematologic cancer	5.79e-05	0.000207	CcSEcCtD
Sulfadiazine—Decreased appetite—Prednisone—hematologic cancer	5.78e-05	0.000207	CcSEcCtD
Sulfadiazine—Rash—Prednisolone—hematologic cancer	5.77e-05	0.000206	CcSEcCtD
Sulfadiazine—Dermatitis—Prednisolone—hematologic cancer	5.76e-05	0.000206	CcSEcCtD
Sulfadiazine—Headache—Prednisolone—hematologic cancer	5.73e-05	0.000205	CcSEcCtD
Sulfadiazine—Vertigo—Epirubicin—hematologic cancer	5.72e-05	0.000205	CcSEcCtD
Sulfadiazine—Leukopenia—Epirubicin—hematologic cancer	5.7e-05	0.000204	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Methotrexate—hematologic cancer	5.55e-05	0.000199	CcSEcCtD
Sulfadiazine—Convulsion—Epirubicin—hematologic cancer	5.52e-05	0.000197	CcSEcCtD
Sulfadiazine—Nausea—Etoposide—hematologic cancer	5.51e-05	0.000197	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Methotrexate—hematologic cancer	5.44e-05	0.000194	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Prednisone—hematologic cancer	5.43e-05	0.000194	CcSEcCtD
Sulfadiazine—Nausea—Prednisolone—hematologic cancer	5.43e-05	0.000194	CcSEcCtD
Sulfadiazine—Arthralgia—Epirubicin—hematologic cancer	5.42e-05	0.000194	CcSEcCtD
Sulfadiazine—Pruritus—Betamethasone—hematologic cancer	5.4e-05	0.000193	CcSEcCtD
Sulfadiazine—Pruritus—Dexamethasone—hematologic cancer	5.4e-05	0.000193	CcSEcCtD
Sulfadiazine—Vomiting—Triamcinolone—hematologic cancer	5.35e-05	0.000191	CcSEcCtD
Sulfadiazine—Rash—Triamcinolone—hematologic cancer	5.3e-05	0.00019	CcSEcCtD
Sulfadiazine—Dermatitis—Triamcinolone—hematologic cancer	5.3e-05	0.000189	CcSEcCtD
Sulfadiazine—Vertigo—Doxorubicin—hematologic cancer	5.29e-05	0.000189	CcSEcCtD
Sulfadiazine—Anorexia—Methotrexate—hematologic cancer	5.29e-05	0.000189	CcSEcCtD
Sulfadiazine—Urticaria—Prednisone—hematologic cancer	5.28e-05	0.000189	CcSEcCtD
Sulfadiazine—Leukopenia—Doxorubicin—hematologic cancer	5.27e-05	0.000189	CcSEcCtD
Sulfadiazine—Headache—Triamcinolone—hematologic cancer	5.27e-05	0.000188	CcSEcCtD
Sulfadiazine—Body temperature increased—Prednisone—hematologic cancer	5.25e-05	0.000188	CcSEcCtD
Sulfadiazine—Abdominal pain—Prednisone—hematologic cancer	5.25e-05	0.000188	CcSEcCtD
Sulfadiazine—Diarrhoea—Betamethasone—hematologic cancer	5.22e-05	0.000187	CcSEcCtD
Sulfadiazine—Diarrhoea—Dexamethasone—hematologic cancer	5.22e-05	0.000187	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Epirubicin—hematologic cancer	5.2e-05	0.000186	CcSEcCtD
Sulfadiazine—Convulsion—Doxorubicin—hematologic cancer	5.11e-05	0.000183	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Epirubicin—hematologic cancer	5.09e-05	0.000182	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	5.06e-05	0.000181	CcSEcCtD
Sulfadiazine—Insomnia—Methotrexate—hematologic cancer	5.02e-05	0.00018	CcSEcCtD
Sulfadiazine—Arthralgia—Doxorubicin—hematologic cancer	5.02e-05	0.000179	CcSEcCtD
Sulfadiazine—Nausea—Triamcinolone—hematologic cancer	5e-05	0.000179	CcSEcCtD
Sulfadiazine—Anorexia—Epirubicin—hematologic cancer	4.95e-05	0.000177	CcSEcCtD
Sulfadiazine—Hypersensitivity—Prednisone—hematologic cancer	4.9e-05	0.000175	CcSEcCtD
Sulfadiazine—Vomiting—Betamethasone—hematologic cancer	4.85e-05	0.000173	CcSEcCtD
Sulfadiazine—Vomiting—Dexamethasone—hematologic cancer	4.85e-05	0.000173	CcSEcCtD
Sulfadiazine—Decreased appetite—Methotrexate—hematologic cancer	4.83e-05	0.000173	CcSEcCtD
Sulfadiazine—Rash—Dexamethasone—hematologic cancer	4.81e-05	0.000172	CcSEcCtD
Sulfadiazine—Rash—Betamethasone—hematologic cancer	4.81e-05	0.000172	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Doxorubicin—hematologic cancer	4.81e-05	0.000172	CcSEcCtD
Sulfadiazine—Dermatitis—Betamethasone—hematologic cancer	4.81e-05	0.000172	CcSEcCtD
Sulfadiazine—Dermatitis—Dexamethasone—hematologic cancer	4.81e-05	0.000172	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Methotrexate—hematologic cancer	4.8e-05	0.000171	CcSEcCtD
Sulfadiazine—Headache—Betamethasone—hematologic cancer	4.78e-05	0.000171	CcSEcCtD
Sulfadiazine—Headache—Dexamethasone—hematologic cancer	4.78e-05	0.000171	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	4.74e-05	0.000169	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Doxorubicin—hematologic cancer	4.71e-05	0.000168	CcSEcCtD
Sulfadiazine—Pruritus—Prednisone—hematologic cancer	4.7e-05	0.000168	CcSEcCtD
Sulfadiazine—Insomnia—Epirubicin—hematologic cancer	4.7e-05	0.000168	CcSEcCtD
Sulfadiazine—Anorexia—Doxorubicin—hematologic cancer	4.58e-05	0.000164	CcSEcCtD
Sulfadiazine—Diarrhoea—Prednisone—hematologic cancer	4.55e-05	0.000163	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Methotrexate—hematologic cancer	4.54e-05	0.000162	CcSEcCtD
Sulfadiazine—Nausea—Dexamethasone—hematologic cancer	4.53e-05	0.000162	CcSEcCtD
Sulfadiazine—Nausea—Betamethasone—hematologic cancer	4.53e-05	0.000162	CcSEcCtD
Sulfadiazine—Decreased appetite—Epirubicin—hematologic cancer	4.52e-05	0.000162	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Epirubicin—hematologic cancer	4.49e-05	0.00016	CcSEcCtD
Sulfadiazine—Urticaria—Methotrexate—hematologic cancer	4.41e-05	0.000158	CcSEcCtD
Sulfadiazine—Abdominal pain—Methotrexate—hematologic cancer	4.39e-05	0.000157	CcSEcCtD
Sulfadiazine—Body temperature increased—Methotrexate—hematologic cancer	4.39e-05	0.000157	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	4.38e-05	0.000157	CcSEcCtD
Sulfadiazine—Insomnia—Doxorubicin—hematologic cancer	4.35e-05	0.000156	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Epirubicin—hematologic cancer	4.25e-05	0.000152	CcSEcCtD
Sulfadiazine—Vomiting—Prednisone—hematologic cancer	4.23e-05	0.000151	CcSEcCtD
Sulfadiazine—Rash—Prednisone—hematologic cancer	4.19e-05	0.00015	CcSEcCtD
Sulfadiazine—Dermatitis—Prednisone—hematologic cancer	4.19e-05	0.00015	CcSEcCtD
Sulfadiazine—Decreased appetite—Doxorubicin—hematologic cancer	4.18e-05	0.000149	CcSEcCtD
Sulfadiazine—Headache—Prednisone—hematologic cancer	4.16e-05	0.000149	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	4.15e-05	0.000148	CcSEcCtD
Sulfadiazine—Urticaria—Epirubicin—hematologic cancer	4.13e-05	0.000148	CcSEcCtD
Sulfadiazine—Abdominal pain—Epirubicin—hematologic cancer	4.11e-05	0.000147	CcSEcCtD
Sulfadiazine—Body temperature increased—Epirubicin—hematologic cancer	4.11e-05	0.000147	CcSEcCtD
Sulfadiazine—Hypersensitivity—Methotrexate—hematologic cancer	4.09e-05	0.000146	CcSEcCtD
Sulfadiazine—Nausea—Prednisone—hematologic cancer	3.95e-05	0.000141	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.93e-05	0.000141	CcSEcCtD
Sulfadiazine—Pruritus—Methotrexate—hematologic cancer	3.93e-05	0.00014	CcSEcCtD
Sulfadiazine—Hypersensitivity—Epirubicin—hematologic cancer	3.83e-05	0.000137	CcSEcCtD
Sulfadiazine—Urticaria—Doxorubicin—hematologic cancer	3.82e-05	0.000137	CcSEcCtD
Sulfadiazine—Body temperature increased—Doxorubicin—hematologic cancer	3.8e-05	0.000136	CcSEcCtD
Sulfadiazine—Abdominal pain—Doxorubicin—hematologic cancer	3.8e-05	0.000136	CcSEcCtD
Sulfadiazine—Diarrhoea—Methotrexate—hematologic cancer	3.8e-05	0.000136	CcSEcCtD
Sulfadiazine—Pruritus—Epirubicin—hematologic cancer	3.68e-05	0.000131	CcSEcCtD
Sulfadiazine—Diarrhoea—Epirubicin—hematologic cancer	3.56e-05	0.000127	CcSEcCtD
Sulfadiazine—Hypersensitivity—Doxorubicin—hematologic cancer	3.54e-05	0.000127	CcSEcCtD
Sulfadiazine—Vomiting—Methotrexate—hematologic cancer	3.53e-05	0.000126	CcSEcCtD
Sulfadiazine—Rash—Methotrexate—hematologic cancer	3.5e-05	0.000125	CcSEcCtD
Sulfadiazine—Dermatitis—Methotrexate—hematologic cancer	3.5e-05	0.000125	CcSEcCtD
Sulfadiazine—Headache—Methotrexate—hematologic cancer	3.48e-05	0.000124	CcSEcCtD
Sulfadiazine—Pruritus—Doxorubicin—hematologic cancer	3.4e-05	0.000122	CcSEcCtD
Sulfadiazine—Vomiting—Epirubicin—hematologic cancer	3.3e-05	0.000118	CcSEcCtD
Sulfadiazine—Nausea—Methotrexate—hematologic cancer	3.3e-05	0.000118	CcSEcCtD
Sulfadiazine—Diarrhoea—Doxorubicin—hematologic cancer	3.29e-05	0.000118	CcSEcCtD
Sulfadiazine—Rash—Epirubicin—hematologic cancer	3.28e-05	0.000117	CcSEcCtD
Sulfadiazine—Dermatitis—Epirubicin—hematologic cancer	3.27e-05	0.000117	CcSEcCtD
Sulfadiazine—Headache—Epirubicin—hematologic cancer	3.26e-05	0.000116	CcSEcCtD
Sulfadiazine—Nausea—Epirubicin—hematologic cancer	3.09e-05	0.00011	CcSEcCtD
Sulfadiazine—Vomiting—Doxorubicin—hematologic cancer	3.06e-05	0.000109	CcSEcCtD
Sulfadiazine—Rash—Doxorubicin—hematologic cancer	3.03e-05	0.000108	CcSEcCtD
Sulfadiazine—Dermatitis—Doxorubicin—hematologic cancer	3.03e-05	0.000108	CcSEcCtD
Sulfadiazine—Headache—Doxorubicin—hematologic cancer	3.01e-05	0.000108	CcSEcCtD
Sulfadiazine—Nausea—Doxorubicin—hematologic cancer	2.86e-05	0.000102	CcSEcCtD
